Vanderbilt Univeristy Ingram Cancer Center (10) — Nashville, Tennessee

Vanderbilt Univeristy Ingram Cancer Center (10) is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Univeristy Ingram Cancer Center (10) has participated in 1 clinical trials.

Therapeutic areas: CML.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Univeristy Ingram Cancer Center (10)?

Vanderbilt Univeristy Ingram Cancer Center (10) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Univeristy Ingram Cancer Center (10) conducted?

Vanderbilt Univeristy Ingram Cancer Center (10) has 1 clinical trials on record. Their work covers CML.

Is Vanderbilt Univeristy Ingram Cancer Center (10) accredited by Crixeo Health?

Vanderbilt Univeristy Ingram Cancer Center (10) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Univeristy Ingram Cancer Center (10)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.